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ABSTRACT 
Background :- Malaria constitutes one of the major health problems in Ethiopia. One of the 
reasons attributed for the upsurge is the development of resistance of Plasmodium falciparum 
and the emergence of multi drug resistant strains of the parasite to anti malarial drugs. A 
continued search for other effective, safe and cheap plant-based ant malarial agents thus becomes 
imperative in the face of these difficulties.  
Objective :- The objective of the present study is to identify phytochemical profiles , evaluation 
of acute toxicity,  sub acute toxicity and the in vivo anti malarial activities of the methanolic 
extracts of Hagenia abyssinica (Bruce) J. F. Gmel. 
 Methods :-  The plant material Hagenia  abyssinica was screened phytochemically for presence 
of secondary metabolites. Acute  toxicity studies of the extracts were also carried out by giving 
up to 2000mg/kg to non infected mice. Weight loss, change in general behavior and mortality 
were used as indicators of toxicity and also evaluated for its antimalarial activity in vivo assays 
against Plasmodium berghei infected  mice using 4 day suppression test. Different doses of 100, 
200 and 400mg/kg crude extracts, chloroquine base 10mg/kg (positive control) and normal saline 
(negative control) administered by an intragastric gavage daily for the treatment period. 
Results :- Qualitative Phytochemical screening showed presence of Anthraquinones, terpinoids, 
saponins, phenols, flavonoides, alkaloids and tannins.The crude extract was non toxic at a single 
dose of 2000mg/kg body weight in acute toxicity study. Antimalarial suppressive test of 
methanol crude extracts at 100, 200 and 400mg/kg showed 65.29%, 79.6%, 83.33 respectively  
indicating that the plant is promising for further investigation.                                                       
Conclusion:- Crude extracts of H.abyssinica  caused strong activities against P. berghei in swiss 
albino mice indicating that they contain some chemical constituents that possibly lead to 
antimalarial drug development. No signs of acute toxicity were observed. Further detailed 
pharmacological and toxicological studies are recommended for drug development.
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1. Introduction 
1.1 Background                                                               
1.1.1  Pathophysiology of Malaria 
 Malaria is a febrile hemolytic disease caused by species of protozoa belonging to the genus 
Plasmodium . There are well over 200 different species of plasmodia and the parasite is capable 
of infecting many animal species such as reptiles, birds, and various mammals.There are four 
main Plasmodium species that cause disease in humans: P. falciparum, P. vivax, P. ovale and P. 
malariae. In addition, a simian parasite, P. knowlesi, occasionally infects humans (1).  
Malaria due to P. falciparum is the most deadly form and it predominates in Africa; P. vivax is 
less dangerous but more widespread, and the other three species are found much less frequently. 
Malaria parasites are transmitted to humans by the bite of infected female mosquitoes of more 
than 30 anopheline species(2).  
1.1.2.  Epidemiology of Malaria   
Globally, an estimated 3.4 billion people living in 104 countries were at risk of malaria ,and an 
estimated 207 million clinical cases which lead to nearly  627 000 deaths in 2013 .of those  
approximately 80% of cases and 90%  deaths are estimated to occur in African Region, with 
children under  five years of age and pregnant women most severely affected.  malaria accounted 
for  post-neonatal child deaths  of  7% globally and 15%  in Africa in 2012. Malaria killed more 
than 1,200 children under 5 years of age every day in 2012. Childhood malaria mortality is 
strongly concentrated in the poorest countries in sub- Saharan Africa (3). 
Malaria economic effect is tremendous and includes direct cost of treatment and prevention, as 
well as indirect costs such as lost productivity from morbidity and mortality, and time spent 
seeking treatment . In Africa it is estimated that economic losses due to malaria amount to about 
$12 billion a year, which by far exceeds the resources needed for malaria control, estimated at 
about $3 billon .it also reduces growth of GDP per capita by 1.3% per year (4). Malaria is ranked 
as the leading communicable disease in Ethiopia, accounting for about 30% of the overall 
Disability Adjusted Life Years lost. According to the FMOH’s health and health related 
indicators report for 2010/11 shows deaths due to malaria in under five years constitute 12.6% 
compared to 21.1% in 2003/04. WHO estimated that there were 5,400 malaria deaths in Ethiopia 
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in 2010 among Ethiopian children under five years of age, but recent surveillance reports the 
annual malaria deaths in 2011 is 550(3,5).  Malaria is present everywhere except in the central 
highlands . FMOH estimates that there are about 12 million suspected malaria cases each year. 
The FMOH reported a total of 3,384,589 malaria cases from July 2011-June 2012, with  (53.0%) 
of these laboratory confirmed, with (59.2%) P. falciparum and (40.8%) P.vivax. Ethiopia 
reported 936 malaria deaths in 2011 (3,6). Over the past years, the disease has been consistently 
reported as the leading cause of outpatient visits, hospitalization and death in health facilities 
across the country (7). About 75% of the geographic area of the country  has significant malaria 
transmission risk (defined as areas <2,000 m) which contains 57.3 million (68%) of the 84.3 
million population of Ethiopia. The transmission of malaria in Ethiopia depends on altitude and 
rainfall with a lag time varying from a few  weeks before the beginning of the rainy season to 
more than a month after the end of the rainy season . Malaria transmission peaks bi-annually 
from September to December and April to May (8). 
1.1.3  Life Cycle of Plasmodium 
 
 Knowledge of the life cycle of the malaria parasite is fundamental to understanding the methods 
of prevention, treatment and research pursuits. Although malaria parasites differ from each other 
in many respects, they have similar basic life cycle. Plasmodium species exhibit a heteroxenous 
life cycle involving vertebrate hosts and arthropod vectors (female Anopheles mosquito). 
Plasmodium species are quite host–specific and there is no zoonosis .  The parasite has a 
complex life cycle and in order to eradicate the disease, Liver stage, Blood stage ,transmission 
stage, Mosquito stage should be considered for treatment .The life cycle of Plasmodium species 
starts when a malaria parasite infected female Anopheles mosquito bites a healthy individual and 
inoculates sporozoites (infective form) into the human host. These sporozoites infect liver cells 
(hepatocytes) within 30 to 40 minutes and mature into schizonts, which rapture the liver cells and 
are released 10,000 to 30,000  merozoites approximately from 6 to 15 days according to species. 
Merozoites released from liver cells start to invade red blood cells within 15 to 20 seconds in the 
blood. However, in P.vivax and P.ovale, some of the sporozoites remain in the liver and become 
dormant hyponozoites. This form can remain for months and years until reactivated to complete 
its life cycle, responsible for secondary erythrocytic schizogony and relapses in patients. In 
erythrocytes the ring stage trophozoites mature into schizonts which rapture to release 
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merozoites, after 48- 72 hours depending on the species, which invade and destroy new 
erythrocytes. The asexual erythrocytic cycle usually continues until controlled by the immune 
response or chemotherapy or until the patient dies (in case of P. falciparum). some merozoites 
differentiate into sexual erythrocytic stages (gametocytes).(9) 
 
 The merozoites  enter into the blood circulation,where they infect red blood cells. They further 
undergo asexual multiplication, some merozoites mature again into schizonts that lead to more 
merozoites; others differentiate into gamet ocytes which, when picked up by a second mosquito 
during a further bite, undergo a series of transformations in this second mosquito, leading 
eventually to the production of new sporozoites that can infect another human being(10).   
 Within the mosquito midgut, the male gametes will fuse with female gametes to create zygotes . 
These zygotes develop into motile ookinetes  that ultimately become embedded in basal lamina 
beneath the midgut epithelial wall as oocysts .after several days, a single oocyst develop to a 
syncytial cell (sporoblast) with thousands of nuclei.In a massive cytokinesis event, thousands of 
haploid daughter sporozoites assemble from the surface of the mother cell , and these infective 
sporozoites then migrate to the mosquito salivary glands for transmission to the host (11). 
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 1.1.4   Malaria Prevention and Control  
 There are a number of approaches towards the prevention and control of malaria and the choice 
of intervention in a country or region are usually most dependent on cost-effectiveness. 
 Some of the factors that contributed to high cost control programs, the emergence of new 
insecticide resistant strains of the vector, creation of new mosquito breeding sites, the problem of 
drug resistance (Plasmodium falciparum) to almost all currently available antimalarial drugs, 
lack of organized health infrastructures and the migration behavior of people that are increase the 
incidence and spread of malaria (12).  
Prevention and control of malaria is being approached on two fronts: treatment with antimalarial 
drugs and Vector control. Early diagnosis and treatment with antimalarial drugs is essential in 
controlling the spread of the disease. By reducing the number of infected humans, the number of 
infected mosquitoes is effectively reduced. This type of control is especially important when 
outbreaks of malaria occur (13). 
Vector control is achieved by creating a barrier between the human host and mosquitoes, 
interrupting their life cycle and reducing vector density. Protect people from being bitten by 
infected mosquito though the use of insecticide-treated nets, insect repellents and indoor residual 
spraying of insecticides to kill the adult or larval mosquitoes, using natural biological controls 
such as the introduction of fish which eat the mosquito’s larvae or bacteria (Bacillus thuringiesis) 
which excrete larval toxins and reducing mosquito breeding sites (14).  
1.1.5 Malaria Treatment and Drug Resistance 
Treatment of sick individuals using correct dose of antimalarial drugs interrupted the life cycle 
of the parasite. Early treatment of cases also reduces transmission by reducing the opportunities 
for mosquitoes to become infected. Antimalarial drugs that eliminate developing or dormant 
liver forms are called tissue schizonticides; those that act on erythrocytic parasites are blood 
schizonticides; and those that kill sexual stages and prevent transmission to mosquitoes are 
gametocides (15). Few available agents are causal prophylactic drugs (capable of preventing 
erythrocytic infection). However, all effective chemoprophylactic agents kill erythrocytic 
parasites before they increase sufficiently in number to cause clinical disease (4). Currently, most 
approved malaria drugs target only the blood stages of the disease. The two exceptions are the 
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combinati on of atovaquone /proguanil which is also effective in clearing parasites from the 
liver, and primaquine. The latter clears not only liver schizonts but also hypnozoites ,the dormant 
liver-stage parasites in P. vivax and P. ovale infections,thus providing what is known as a radical 
cure.Antimalarial drugs fall into groups.The first are quinoline based antimalarials,which 
includes quinine and its derivatives chloroquine (CQ), amodiaquine, premaquine and mefloquine 
and The second class is the Antifolate compounds that inhibit the synthesis of parasite 
pyrimidines and thus of parasitic Deoxyribonuclic acid (DNA) . The third class of antimalarial is 
based on the natural endoperoxide Artemisinin.Artemisinin and its semi synthetic derivatives 
(dehydroartemisinin (DHA), artemether, arteether, artesunate, artelinic acid are the most rapidly 
acting and effective against multi-drug resistant strains of the parasite(16).   
Currently available antimalarial drugs
ARTEMISININ 
COMBINED 
THERAPY (ACTs)
•Artemether-
lumefantrine (Coartem)
•Artemisinin-piperaquine
•Dihydroartemisinin-piperaquinr
•Artesunate – mefloquine
•Artesunate-pyronaridine
•Artesunate -sulfadoxine/ 
pyrimethamine
•Artesunate - amodiaquine
•Chloroquine
•Sulfadoxine/ 
Pyrimethamine
•Quinine
•Mefloquine
•Atovaquone –
Chloroguanide
•Antibiotics 
Primaquine
Espino, FE, PIDSP Annual Convention February 2012
 
figure. 2  anti malaria  drugs site of action  
 Antimalarial drug resistance is a major concern for the global effort to control malaria(17). 
Resistance to antimalarial medicines has been documented in all classes of antimalarials, 
including the artemisinin derivatives, and it is a major threat to malaria control. Widespread and 
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indiscriminate use of antimalarials exerts a strong selective pressure on malaria parasites to 
develop high levels of resistance. Resistance can be prevented, or its onset slowed considerably, 
by combining antimalarials with different mechan P. falciparum resistance to artemisinins has 
been detected in four countries in South East Asia: in Cambodia, Myanmar,Thailand and Viet 
Nam isms of action and ensuring very high cure rates through full adherence to correct dose 
regimens(6,8,12,). With the increase in cases of drugs resistance and absence of vaccine, there is 
an urgent need for new antimalarial drugs with novel modes of action. One approach to this is 
the investigation of medicinal plants and natural products. 
1.1.6 Antimalarial Drugs from Traditional Medicinal Plants 
The isolation of bioactive compounds from medicinal plants, based on traditional use or 
ethnomedical data, is a highly promising potential approach for identifying new and effective 
antimalarial drug candidates (18). Historically the majority of the drugs have been derived from 
medicinal plants or structures modeled on plant lead compounds, more than 50% of all drugs in 
clinical use today contain certain substances of natural origin, most of these products are from 
plants (19). Previous findings of antimalarial agents such as quinine obtained from Cinchona 
species and artemisinin obtained from Artemisia annua (Qing hao) from medicinal plants also 
encouraged the possibility of finding new antimalarial drugs from plant sources (20).  
 Hence it is possible that the investigation of traditional medicinal plants used in the treatment of 
malaria may lead to the discovery of new antimalarial compounds . Traditional knowledge can 
be a fundamental starting point for chemotherapeutic research. A principal approach to 
chemotherapeutic research against malaria consists of investigating the traditional medicinal 
plant based antimalarials . The strategy of developing new drugs based on medicinal plants has 
an advantage over random screening, since it is guided by experience from a long history of 
clinical practice. Only 1% active plants among 300 randomly selected species which were tested, 
nearly 20% were found to be active among less than 50 plants based on traditional knowledge, 
identified up to the present (21). Plants investigated for pharmacologically active compounds are 
usually selected on the basis of ethnomedicinal information as there is a correlation between 
biological activity and the traditional use of the plant . In developing a drug from a plant attempts 
may be made to produce chemical analogues of the active principles with enhanced 
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antiplasmodial activity and reduced host toxicity drug research over the last two decades (22).                                                        
The investigation of a range of plants from various countries used in traditional medicine for the 
treatment of malaria has led to the discovery of a large number of antimalarial compounds with 
significant structural variety. Examples of compounds with antimalarial activity isolated from 
traditional medicinal plants are quinines, triterpenes, sesquiterpenoids, quassinoids, liminoids, 
alkaloids  and coumarins (23). 
 The urgency generated by drug resistant strains of malaria has accelerated antimalarial drug 
research over the last two decades . In malaria therapy, 11 drugs out of the antimalarials included 
in WHO therapeutic schemes for malaria treatment are natural products or their analogues or 
were design-based on the pharmacophores from natural products .The great significance of plant-
derived drugs for the treatment of the disease is highlighted by quinine (derived from Cinchona 
tree), artemisinin (derived from Artemisia annua) and atovaquone , which is a synthetic 
compound  analogue of lapachol from the Tabebuia species (24).  
 A number of in vivo and in vitro studies have been conducted to evaluate antimalarial activities 
of Ethiopian medicinal plants, Animut (25) showed that the  water extracts of V. amygdalina leaf 
and methanol extract of Croton macrostachyus fruits have significant suppressive effect against 
P. berghei in vivo. Teklemariam (26)  evaluated the antimalarial activities of Moringa 
stenopetala, W. somnifera and V.amygdalina against P.berghei in mice model showed valid 
results., Dikasso et a. (27) evaluated . The hydroalcoholic extracts from the roots and aerial parts 
of Asparagus africanus Showed significant antimalarial activity in the Swiss albino mice by 
46.1`% and 40.7% respectively 
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 1.2  Literature Review                                                                                                                                                                                                                                                                                   
1 .2.1  The family Rosacea                                                                                                                                                                                                                                       
Rosaceae, in the order Rosals, is a large family containing more than 100 genera and 2,000 
species of herbs, shrubs and trees of economic value, both for food (e.g., fruit trees including 
plums, apples, pears, loquats, blackberries and strawberries) and as ornamentals (e.g., flowers of 
the genus Rosa) . This family is represented on all continents except Antarctica, but the majority 
of species are found in Europe, Asia and North America (28).  
1.2.2  The Genus Hagenia 
Hagenia abyssinica (Bruce) J. F. Gmel is commonly known as Kosso in Ethiopia belongs to a 
monotypic genus in the family Rosaceae. It is a deciduous  tree with distinct male and female 
trees, both of which are endowed with colourful flowers. The tree attains heights of up to 20 m, 
with short trunk and thick branches.The flowers are greenish, or white, turning reddish with 
maturity in female flowers.  In Ethiopia, H. abyssinica was once abundant in the semi-humid 
mountain woodlands with the altitudinal range of between 2,450 and 3,250 m .The species 
occurs naturally within the undifferentiated Afromontane .The tree is so dominant in the 
mountains of tropical Africa. Outside Ethiopia,  H. abyssinica is reported from the mountainous 
regions of Kenya, Tanzania, Malawi, Zimbabwe, Zambia, Zaire, Burundi, Uganda & Sudan (29). 
      
Fig. 3     Hagenia abyssinica (Bruce) J.F      
 
9 
 
1.2.3  Medicinal Use  of H. abyssinica 
 The female flowers of Kosso have long been used to expel tapeworm, a very common 
infestation among Ethiopians due to the age-long practice of eating raw beef by a large sector of 
the population (30,31).The traditional healer  claims that  kosso are also useful in treatment of 
high blood pressure ,  Fever/cough, Intestinal worms (tape worm) Stomachache, Diarrhea , 
healing of wound, Typhoid ,Cold (bronchitis) ,Epilepsy ,Livestock disease (thin/skinny body) , 
Evil eye ,Hepatitis, Sexually Transmitted Diseases (STDs), Throat disease, Proble ms related to 
Bile Cancer (mixed with other plants), Dermatology, Malaria ,and diabetes (32). 
 In East Africa the roots of H.abyssinica are cooked with meat and the soup drunk against 
general illness and malaria, besides its use as an anthelmintic. It is used in the treatment of 
syphilis together with powdered bark of Albizzia anthelmintica and also Against scrophulous 
tumour and cough. Between 1817 &1954, Hagenia abyssinica (Bruce) J. F. Gmel (kosso) was 
listed in the pharmacopoeias  of 29 countries(30,31). 
 Women uses the bark of  H. abyssinica  during childbirth to prevent blood clotting  and also uses 
to treat skin diseases .The seeds and the resin are toxic and are used as a fish poison. decoction of 
the roots is used as a laxative. oil of the seed is used against ear-inflammations.The soup of the 
leaves for headaches; inhaling smoke from burning leaves or drinking the leaf-sap is said to 
relieve pains of a woman in labour;chewing the root, bark or wood relieves toothache. A 
decoction of the leaves or the ash of burned leaves, is used against coughs. Besides being a 
source of medicine, Hagenia abyssinica has been utilized for various other purposes such as 
construction, furniture, fuelwood, and soil fertility management. As a result of its enormous 
significance,H. abyssinica is one of the endangered tree species in the country due to over 
exploitation (29,33). 
 1.2.4  The Chemistry of Hagenia abyssinica 
Several secondary metabolites characterize the chemical composition of the Hagenia abyssinica. 
As active principles in this species, four phloroglucinol derivatives have been isolated.These are 
kosotoxin, protokosin,koisdine and kosine . The constituent responsible for its medicinal value is 
the phenolic compound, Kosin which is isolated from the ether extracts of the female flowers of 
Kosso.Kosins exhibits comparable potency as the marketed drugs, Dicholorophin &Nicolsamide. 
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Male flowers are not used traditionally as taeinicides due to their alleged high toxicity (34).The 
bitter principle called  α kosin and β kosin, which are found in kosso, are thought to be 
decomposition products. Kosotoxin, a yellow amorphous powder possibly related to filicia acid 
and Rottlerin, is the principal constituent of kosso   Where as protokosin and kosidin are inactive 
colorless bodies found in the extract of kosso . it also have  Volatile oil, a bitter acrid resin, and 
tannic acid.( 35) The methanol  extract has been also isolated quercetin 3-O-β-glucuronide 
,quercetin 3-O-β-glucoside , rutin and quercetin glycuronide (36). 
  
Figure .4    Protontoxin                                                            kosin 
1.2.5  Pharmacologic Activity  
  Spasmolytic  activity :- Kosso relieve non specific abdominal complaints which could arise 
from high secretion of acetylcholine and histamine in the gastro intestinal tract (37).  
 Kosin  isolated from Hagenia abyssinica, showed anthelmintic  as well as  cytotoxic activity 
against a panel of three transplantable murine colonic adenocarcinomas with varying growth 
characteristics and morphology . Significant reductions in colony formation were observed 
tumour cell (38) .The hexane extracts of leaves of H. abyssinica were the most active extracts 
with the highest zones of inhibition  against S. aureus, MRSa and P. aeruginosa (39). 
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1.3  Justification of The Study                                                                                            
Antimalarial drug resistance has emerged as one of the greatest challenges facing malaria control 
Today.Drug resistance has been implicated in the spread of malaria to new areas and  played a 
significant role in the occurrence and severity of epidemics.The spread of multi drug-resistant P. 
falciparum has highlighted the urgent need to develop new antimalarial drugs ,that prevent 
transmission, stop relapse and provide long-duration molecules for chemoprotection against new 
infections and preferably inexpensive drugs that are affordable for developing countries, where 
malaria is prevalent (40,51).). 
Globally, over 1000 plants have been used as potential antimalarials in resource-poor settings 
due to fragile health-care systems and lack of accessibility and affordability of artemisinin-based 
combination therapies (ACTs).Those plant  have been in the past the source of some of the most 
successful antimalarial agents such as the quinolines and the endoperoxide artemisinin( 42).  One     
of the areas for the search for new anti malaria is the traditionally claimed antimalarial plants 
from the African flora. Studies have been conducted on traditionally claimed medicinal plants in 
Ethiopia and elsewhere for scientific validation. This is because they have been part of human 
life since time immemorial; & a number of plant products have been in extensive use in 
ethnomedicine (43).Finally Natural products have made and continue to make an immense 
contribution to malaria chemotherapy either directly as antimalarial agents or as important lead 
compounds for the discovery of more potent antimalarials. In the endemic area where malaria 
prevails, traditional herbal medicines are often used for antipyretic therapy and antimalarial 
therapy. However, very little scientific information is available to assess the efficacy of these 
herbal remedies. Therefore, it is important to investigate the safety and efficacy of antimalarial 
activities of medicinal plants that have a traditional claim in order to determine their potential as 
sources in the development of new antimalarial drugs. That is why this study is undertaken to 
evaluate the in vivo antimalarial activities of crude methanolic stem bark extracts of Hagenia 
abyssinica against P.berghei in laboratory bread Swiss albino mice to further substantiated the 
traditional use for malarial treatment (40,42).  
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   2. OBJECTIVES  
2.1 General objective  
 To evaluate the anti malarial activity ,acute and sub acute toxicity of the crude 
haydroalcoholic extracts of the Stem bark of Hagenia abyssinica (Bruce) J. F. Gmel 
(Rosaceae) against P.berghei in swiss albino mice. 
2.2. Specific objectives  
 To assess the acute and sub acute toxicity of crude methanolic extracts of the  Stem Barks 
of Hagenia abyssinica (Bruce) J. F. Gmel (Rosaceae) in Swiss albino mice. 
 To identify secondary metabolites in crude methanolic extracts of the stem bark of 
Hagenia abyssinica (Bruce) J. F. Gmel (Rosaceae).  
 To evaluate the antimalarial effects of crude methanolic extracts of the Stem Bark of       
Hagenia abyssinica in Swiss albino mice infected with P. berghei. 
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3. Materials and Methods  
3.1 Materials and Animals 
3.1.1 Plant Material  
The stem  barks of H. abyssinica  was collected in December 2013 from kossoye  kebele  780  
Km North west of Addis Ababa, Central Ethiopia. The authenticity of the plant material were 
confirmed,by  the National Herbarium, Department of Biology, Addis Ababa University, where 
voucher specimen (collection number Tm 01) deposited.  
3.1.2  Reagents and Drugs  
Table.1 chemicals and reagents used in the experiments.  
Chemicals  Manufacturer    Obtained from Country 
Chloroquine EPHARM Gondar Private pharmacy Ethiopia 
Methanol Avishkar Labtechche PFSA, Addis Ababa-Ethiopia India 
Ammonia BDH Chem ltd Poole Dep`t of pharmacognocy, UOG England 
Ferric chloride  AvishkarLabtechche Dep`t of pharmacognocy, UOG India 
Glacial acetic acid CDH Labor reagent Dep`t of pharmacognocy, UOG india 
Sulfuric acid Supertek chemicals Dep`t of pharmacognocy, UOG India 
Acid alcohol AvishkarLabtechche Dep`t of pharmacognocy, UOG India 
Meyers reagent Supertek chemicals Dep`t of pharmacognocy, UOG India 
Draggendorffs 
reagent 
Supertek chemicals Dep`t of pharmacognocy, UOG India 
ninhydrin reagent Supertek chemicals Dep`t of pharmacognocy, UOG India 
Lead acetate Supertek chemicals Dep`t of pharmacognocy, UOG India 
Hydrochloric acid Supertek chemicals Dep`t of pharmacognocy, UOG India 
Nitric acid Supertek  chemicals Dep`t of pharmacognocy, UOG India 
Giemsa AvishkarLabtechche Dep`t of pharmacology, UOG India 
Sodium citrate AvishkarLabtechche Dep`t of pharmacology, UOG India 
 
All the chemicals were analytical grade & most of them were obtained from school of pharmacy 
in UOG. 
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3.1.3 Experimental Animals  
Male and female Swiss albino mice weighing 24-30 g and age 6-8 weeks were obtained from 
university of Gondar , animal house, Gondar . All animals were housed in an air-conditioned 
room and were allowed to acclimatize for one week before the study. The animals were kept at 
room temperature and were exposed to a 12 hour light/dark cycle. All the experiments were 
conducted in accordance with the internationally accepted laboratory animal use, care and 
guideline(44). Before and during the experiment, the mice were  allowed free access to standard 
pellets and water ad libitum. 
3.1.4Parasite                                                                                                                       
Plasmodium berghei ANKA strain (chloroquine sensitive), was  purchased from Aklilu Lemma 
Institute of Pathobiology. The parasite was subsequently maintained in the laboratory by serial 
blood passage from mouse to mouse on weekly basis. 
3.2. Method 
3.2 .1 Preparation of Plant Material   
The bark of H. abyssinica was cleaned, air-dried at room temperature and crushed into coarse 
powder. The powdered plant material (100 g) was  macerated in one liter 80% methanol (Lab 
tech chemicals, CASR NO 67-56-1 A.B.NO- 130507) for 72 h with occasional stirring. The 
filtrate was separated from the mark using Whatman filter paper 18cm diameter and 0.1μm pore 
diameter and the mark was re-macerated two times. The filtrates were combined and dried in an 
oven (Gallenkamp, England) at the temperature not exceeding 40℃. The dried extract was  
transferred into vials and were kept in a desiccators until use.  
  3.2 .2  Preliminary Phytochemical Screening  
The 80% methanol extract of H.abyssinica  was screened for the presence of alkaloids, 
flavonoids, polyphenols, tannins, saponins, terpinoide, antraquinone, resin  and steroidal 
compounds(49,50). 
 
 
 
15 
 
 3.2.3 Acute oral Toxicity Test  
A preliminary toxicity study was designed to demonstrate the appropriate safe dose range that 
could be used for subsequent experiments rather than to provide complete toxicity data on the 
extract and the acute toxicity of Hagenia abyssinica. The methanolic stem bark extract was 
carried out using OECD-425 guide lines .The study mice was fasted for 4 hours.A single limit 
dose of 2g/kg stem bark extract was administered to a total of 5 female Albino mice(22-25g 
each) within 24 hour interval. The mice were observed for 14 days to asses signs of toxicity and 
death (45).   
3.2.4 Sub Acute Toxicity Test 
The crude methanol extracts of Hagenia abyssinica intended for the antimalarial test against     P. 
berghei were evaluated for its toxicity in non-infected male and female Swiss albino mice aged 
6-8 weeks and weighing 27-32 gram. For the test, 12 mice were used by randomly dividing them 
into four groups of 3 mice per cage. Before oral administration of a single dose of each extract, 
the mice were fasted for 3 hours . For subacute toxicity studies weight and PCV were measured 
before and after treatment. The extracts in each case was administered orally in an increasing 
dose related manner for four days (i.e. D0 to D4) using gavage. Then, the mice in group one, two 
and three were given orally 100, 200 and 400mg/kg body weight in single dose volume of 0.2 ml 
of each extract, respectively. The mice in the control groups received 0.2 ml of respective vehicle 
of each extract. Then, the mice were observed continuously for one hour after the treatment; 
intermittently for 4 hours, and there after over a period of 24 hours.The mice were also observed 
for gross behavioral changes such as feeding, lacrimation mortality and other signs of toxicity 
manifestations for 24 hours. 
 In subacute toxicity studies, the mice were closely observed for a week and data were recorded 
on day 0 and day 4 (after 12 hours of the last dose given). The subacute toxicity of each extracts 
was evaluated in terms of gross behavioral changes, mortality, weight loss, Organ weight loss 
and reduction in PCV. The body weight of each mouse was determined in grams using weighing 
balance. The packed cell volume was determined by microhaematocrit reader. The mice were 
dissected and liver, kidney lung  and heart were excised and weighed.  
Data on weight, Organ weight, packed cell volume, were obtained on day zero (D0) and day four 
(D4). For all experimental mice, the averages of all parameters before treatment (D0) and after 
treatment (D4) were compared with control group and among different dose levels (15). 
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3.2.5  Antimalarial Activity Test of the Crude Extract  
The standard four-day suppressive method was used (46,47). Blood was taken from a donor 
mouse by cardiac puncture with approximately 30% parasitemia and diluted in physiological 
saline to 5x107 parasitized erythrocytes per ml. Swiss albino mice weighing 26-32g were 
infected with 0.2 ml (1x107 parasitized erythrocytes) P. berghei intraperitoneally (i.p) &  
randomly divided into five groups of five mice per cage with three test groups and two control 
groups (each for chloroquine as a standard drug and distilled water as a negative control). The 
test extract was prepared in three different doses (100 mg/kg, 200 mg/kg, and 400 mg/kg of body 
weight) and chloroquine phosphate USP (EPHARM B. No-1041213), at 10 mg/kg in a volume 
of 0.2 ml. Each extract or the standard were administered as a single dose per day. The extract 
and the drug were given through oral route by using standard oral gavages. Treatment was 
started 3 hour after infection on day 0 and were then continued daily for four days (i.e. from day 
0 to day 3).  On the fifth day (D4) thin and thick smears of blood films were obtained from the 
peripheral blood on the tail from each mouse. The smears was  placed on microscopic slides 
(Westtmed Praxis, Germany), was fixed with methanol (EPHARM B. No-7051213) and stained 
with 10% Giemsa at pH 7.2 for 15 minute.   
[                                                                                                                                        
The parasitaemia level was determined by counting the number of parasitized erythrocytes out of 
six random fields of the microscope (Olympus 6V20 WHA2, Japan). Average percent 
parasitaemia and suppression was  calculated by using the following formula (48). 
 Parasitaemia =            Number of parasitized RBC         x   100      
                                    Total number of RBC count 
% Suppression = Mean parasitemia of negative control -_ Mean parasitaemia of treated  x 100 
                             Mean parasitemia of negative control 
 
 
 
 
 
17 
 
 3.2.6. Determination of Body Weight and Temperature 
The body weight of each mouse in all  group was taken before infection (day 0) and on day 4. 
The rectal temperature of the mice was measured with a digital thermometer before infection, 
three hours after infection and then daily up to day 4 to see the effect of the extracts on body 
temperature. 
3.2.7  Determination of Mean Survival Time 
Mortality was monitored daily and the number of days from the time of inoculation of the 
parasite up to death was recorded for each mouse in the treatment and control groups throughout 
the follow up period. The mean survival time (MST) for each group was calculated as:-  
                             MST=    sum of survival time of all mice in a group(daily 
                                                  Total number of mice in the group 
3.2.8  Data Quality Control  
Data quality was controlled by use of appropriate number of animals, randomization , coding  
and use of instruments and chemicals from appropriate sources.                                                                                                         
3.2.9  Data Analysis   
Data was analyzed using Windows SPSS Version 16. The one-way analysis of variance 
(ANOVA) followed by Tukey‟s HSD post-hoc test, was used to compare results among and 
within groups . Paired t-test were also used to compare some parameter between initial and final 
results. The results were considered significant when P<0.05.                                                                                                         
3.3  Ethical Considerations  
The animals were handled according to the international animal care and welfare guidelines (35).  
The ethical clearance were requested and obtained from research and ethics review committee of 
University of Gondar.                                                                                                                                      
 
 
 
.  
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4. Result 
4.1 Percentage Yields of Crude Extract  
 The 80% methanol bark extract of Hagenia abyssinica gave a redish brown solid poweder.                    
The percentage yields of the crude extract was  4.68 %. 
   4.2  Phytochemical Study  
The Phytochemical tests revealed the presence or absence of major secondary metabolites in the 
extracts of the stem barks of H. abyssinica  by using specific chemicals and methods. The results 
obtained from the tests were summarized . 
Table 2: Secondary metabolites of methanol extract of the stem bark of H.abyssinica.                                                                                                                    
Secondary metabolite Reagent                    Result  
Alkaloids Mayer’s Test /Wagner’s Test:   +Ve 
Antraquinone  Ninhydrin Test:   +Ve 
steroides Molisch’s Test /Benedict’s Test   -Ve 
Cardiac glycosides Legal’s Test   -Ve 
Terpinoide Copper acetate Test  +Ve 
Flavonoids Alkaline Reagent Test /Lead acetate Test   +Ve 
Phenols Ferric Chloride Test  +Ve 
Phytosterol Salkowski’s Test /Salkowski’s Test   +Ve 
Resin Resin test   +Ve 
Saponines Froth Test /Foam Test   -Ve 
Tannins Ferric Chloride Test  +Ve 
Note: -          -ve   negetive       +ve  positive 
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4.3  Toxicity Test  
 The acute toxicity study indicated that of the extract did not cause mortality of mice within 24 
hrs up to 2000mg/kg. Gross physical and behavioral observation of the experimental mice also 
revealed no visible signs of acute toxicity like  lacrimation, hair erection, tremors, convulsions, 
salivation and reduction in their motor and feeding activities. They were physically active. 
 4.4   Sub-Acute Toxicity 
Table 3. Sub-acute toxicity tests of the hydroalcoholic stem bark  extract of Hagenia abyssinica 
on body weight and PCV. 
Dose(mg/kg/day)   Parameters D0 +SEM D4 +SEM % change        p-value 
100 
 
Weight (g) 29.3±4.3         25.45±4.1        - 13.14%)               0 .025 
PCV (%)         57.67± 3.05     64±3.51 +10.97%              0 .089                   
200 Weight (g) 30.4±2.5            25.4±.49         -16.3%                  .007                                   
PCV (%)         59.66±2.2           63.±3.0              5.58                     0 .063 
400 Weight (g) 32.33±2.73          27.6±3.59          - 17.14                0 .037 
PCV (%)         66.33±3.38          71.33±.66         +7.54                    0.342 
Vehicle Weight (g) 27.67±3.61           25.3±3.56         -  8.56                  0 .149 
PCV (%)         60.00±.577        59.6±3.5           0 .5                          0.874 
SEM – standard error of mean                                        P<0.05 was considered significant 
Day 0 = day infection was initiated                                 Day 4 = 5th day of infection                          
As shown in Table- 3 statistically significant differences (P<0.05) was observed in weight when 
we compare in each group between pre-treatment (D-0) and post-treatment (D-4) but not 
significant weight variation observed in control group(P>.05). Similarly, slight increase in PCV 
was recorded in extract treated group while there was very small decrease of this parameter on 
day 4 relative to day 0 in negative control group, which was statistically not significant(p>.05).  
The sub-acute toxicity test revealed the non toxic effect of the extract at the given dose. 
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Table 4:-   Sub-acute toxicity tests of the hydroalcoholic stem bark  extract of Hagenia abyssinica  
on organ weight in Swiss Albino Mice 
Organs  Control  100mg  200mg  400mg  
Liver  1.31±0.18  1.58±0.120  1.18±0.22  1.49±0.07  
Kidneys  0.32±0.06 0.39±0.05  0.21±0.06  0.33±0.05  
heart  0.14±0.01  0.16±0.01  0.13±0.03  0.15±0.01  
lung  0.27±0.01  0.34±0.04  0.21±0.04  0.25±0.01  
 
As shown in table -4  the organ weights of liver, kidney, heart and lung did not record any 
significant alterations (P>0.05) in all the treated groups when compared to control group.    
Generally,Sign of toxicity such as change in animal behaviour, lacrimation, weight loss, hair 
erection and mortality were not recorded both in acute and sub-acute toxicity testing. This fulfils 
the criteria set by OECD -425, lack of acute toxicity by the plant extract. 
   4.5   Effect of  Extract on Parasitimia 
 The result of Antimalarial suppressive test of crude methanol extracts of H. abyssinica against 
drug sensitive , P.berghei (ANKA strain), in mouse  possesses blood schizontocidal activity in 
the early infection as shown in table -5 .The multiple comparison tests indicated that all the mice 
treated with the three extracts resulted in reduced parasite load as compared to their respective 
negative control groups. The extracts did not clear the parasite completely, where as positive 
control groups treated with CQ phosphate, used as a standard antimalarial drug, at daily dose of 
10mg/kg body weight totally cleared the parasite on day four under identical condition. Hence, 
the extract was less potent than CQ phosphate. 
Table:- 5  Antimalalarial activities of hydroalcoholic stem bark  extract of H.abyssinica  in  Swiss 
albino   mice infected with P. berghei 
Drug/extract N Average % Parasitaemia Average% suppression 
Control 5 24+1.87 0.0 
100mg/kg 5 8.33+1.67 65.29+1.7 
200mg/kg 5 5+1.45 79.6+2.2 
400mg/kg 5 4+1.87 83.33+4.3 
Chloroquine 5 0.0 100+0 
N – number of mice in each group          P<0.01 was considered significant 
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Hydroalcoholic stem bark  extract of H. abyssinica  showed statistically significant (P<0.001) 
percentage of Parasitaemia against P.berghei at all dose levels (100-400mg/kg) tested  mice 
compared to the mice in the negative control group on day 4. The average percent of 
parasitaemia observed at a highest dose (400 mg/kg/day) was found to be 4.0±1.87 with 83.33% 
of chemosuppression. A dose of 200 mg/kg/day of the extract showed 5.0±1.87% parasitemia 
with 79.6% chemosuppression, while the lowest dose (100 mg/kg/day) lowered the average 
percent parasitemia to 8.33±1.67 with chemosuppression of 65.29% where as the corresponding 
figure in the negative control group was 24.0±01.87%. This reveals that the parasitemia in the 
experimental mice were lower than that of the negative control groups and  the extract has dose 
dependent activity. 
 Comparasion of  percentage of Parasitemia of the lowest dose (100 mg/kg/day) with distil water 
and CQ phosphate it is statically significant with p-value of P<0.001 and P<.022 respectively  
but when we compare  it with 200mg and 400mg  it is not statically significant with  p- value of 
p> .651 and p> .411  respectively.   When we compare  200mg with 400mg and CQ phosphate it 
is not statically significant with  p-  value of p> .989 and p> .166  respectively but statically 
significant with distil water with p-value of P<.001. When we compare  400mg with CQ 
phosphate it is not statically significant with  p- value of  p> .351 but statically significant with 
distil water P<.001.                                                                                                              .                                                                           
4.6  The Effect of H.abyssinica  Extract on Body Temperature                                                     
                                                                                                                                                                    
Figure.5  Effect of extract on body temperature                                                                                                      
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In all three models, the hydromethanolic stem bark extract of H.abyssinica did  cause  prevention  
of rectal temperature reduction of P. berghei infected mice when we compare with distle water 
treated mice but not  statically significant (p>.05). The standard drug, chloroquine 10 mg/kg had 
showed statically significant(p=.036) activity in prevention against rectal temperature reduction 
when compared to the  negative control as shown in the figure - 5 . 
 4.7   Effect of the H.abyssinica Extract on Body Weight                                                                               
Table 5. The effect of the extract on body weight 
Drug/extract      Dose(mg/kg/day) N Weight D0±SEM    Weight D4±SEM       % change        p-value 
H.abyssinica 100 5 30.3±.73                25.5±.63                  15.8%          .001        
H.abyssinica 200 5 27.4±.63                23.3±1.14                14.96           .033 
H.abyssinica 400 5 29.9±.66                25.0±.38                 16.38           .003                                   
Chloroquine 10 5 24.6±.66                22.4±.92                 8.9               .223                               
Vehicle 0.2 ml       5 24.4 ±1.30            22.4 ±.92                8.2               .140 
Day 0 = day infection was initiated  ,         Day 4 = 5th day of infection              = Decrease in average body weight          
N – number of mice in each group             P<0.05 was considered significant                 
 In 4-day suppressive test all dose levels of extract of H.abyssinica had shown body weight loss 
between days 0 and 4 in both control and extract treated groups. All mice had lost some of their 
body weight but still  the control group mice had better body weight status than the extract 
treated mice. There was a significant (p<0.05) loss of body weight between days 0 and 4 in 
extract treated groups but not statically  significant(p>.05) in positive and negative  control 
groups  as shown in table 5. All dose of the crude extract  was found to significantly reduce body 
weight of healthy mice. 
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4.8  Effect of the H.abyssinica Extract on Survival Time  
Table 6. Mean survival time of Plasmodium berghei infected mice after treatment with the 
hydroalcoholic bark extract of Hagenia abiyssinica  
Drug/extract          N Dose (concentration) 
mg/kg/day           
Survival time ± 
SEM 
p-value 
Vehicle 5 0.2 ml                                                      6.8±0.37 - 
H.abyssinica 5 100     10.0 ±.58       .015 
H.abyssinica 5 200 12.2±1.17   .000 
H.abyssinica 5 400 15.2±.97   .000 
chloroquine 5 10 28.0±.00   .000 
 
SEM – standard error of mean       N – number of mice in each group           P<0.05 was considered significant                 
The mean survival time of mice of the given extract was shown to be 10.0±0.57, 12.40±1.16, 
15.2±0.97 days, for doses of 100, 200 and 400 mg/kg/day, respectively, which was statistically 
significant (P<0.05) when compared to Vehicle treated mice which was 6.8±0.37 days as shown 
in table 6. The mean survival time increases as dose the increases which is dose dependent. All 
animals treated with the standard drug, chloroquine 10 mg/kg/day, survived more than 28 days. 
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5. Discussion  
  Most common antimalarial plants used to treat malaria in traditional medicine contain 
secondary metabolites .The phytochemical screening of hydromethanolic stem bark extract of 
H.abyssinica  indicated the presence of  different secondary metabolites that have antiplasmodial 
activity in other plants like  flavonoids(51), terpenoids(52), phenols(53), phytosteriods,Tannins , 
alkaloids(54),Anthraquinones(55).which have been suggested to be responsible for 
antiplasmodial activity of stem bark of H.abyssinica. As the antiplasmodial activity observed in 
many plants  was considered to result from single or combined action of these metabolites, same 
could be said for the present study. 
The phenols present in this plant which have antioxidant effect (56) may also contribute to the 
antimalarial activity due to inhibition of haem polymerization.  The phytosteroids and flavonoids 
detected in this plant could as well be responsible for the antimalarial effect as these metabolites 
have been proved to possess potential immunomodulatory effects in other plants (42). 
    The acute toxicity of H.abyssinica has been investigated to determine any adverse effect that 
may arise as a result of a short time mice exposure to the methanol extract H.abyssinica .None of 
the test mouse died or showed  signs of acute toxicity within 24 hours of treatment with the test 
extracts. So the extracts were nontoxic to the test mice, as they did not show signs of acute 
toxicity within 24 hours at the doses of 2g/kg body weight . 
Similarly, in sub acute toxicity study of the extracts revealed no signs of toxicity manifestations 
within 14 days  at the dose levels tested. But causes significantly loss of weight at all dose levels 
compared to the controls. It may possibly indicate the appetite suppressive effects  of the 
extracts, which would reasonably increase with  increasing dose. This in turn can affect the 
feeding  capability of the mice and could cause a relative  reduction in body weight. which could 
be indicative of  toxicity. However, the toxicity tests of the present study  do not indicate any 
other toxicity manifestation at  reasonably higher doses and no death was observed  before five 
days. This shows that, all the test extracts were non-toxic to the test mice (27). 
 In this study, the anti-plasmodial activity of H.abyssinica was investigated using in vivo animal 
(mice) model. Mice were used to predict the antimalarial activities of the extract because 
Synthetic antimalarial drugs like chloroquine, mefloquine and more recently artemisinin have 
been investigated using mice model (46).   The In-vivo  Plasmodium models such as P.berghei, 
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P. vinckei and P. yoelii are firmly established models in anti-malarial drug discovery  .             
The parasite P. berghei was used to predict treatment outcomes  since it is accessible and 
sensitive to chloroquine  , it was  used as reference drugs(57). When a standard antimalarial drug 
is used in mice infected with P. berghei, it suppresses parasitemia to non-detectable levels , 
which is in agreement with the effects of chloroquine in this study (58). 
The 4-day suppressive test is a standard test commonly used for antimalarial screening, and the 
determination of percent inhibition of parasitemia is the most reliable parameter. It also provides 
a preclinical indication of potential bioactivity of the test sample (59).The life prolonging 
potential of the methanol extract of H.abyssinica in malaria infected mice could be seen from its 
prolongation of the mean survival time. The mice treated with the extract had significantly 
longer survival time than the negative control mice, which did not survive longer than 6.8  days. 
This effect has value in patient care whereby the extracts could be used until such time that 
curative medication can be found for proper treatment of malaria patients. According to Peters 
(47) The mean survival time of mice is considered as an evidence for the antiplasmodial activity 
of the extract. There was lower parasitaemia level in the extract administered group and longer 
survival time of the mice at the highest doses of the extract  indicating strongly associated with a 
dose dependent pharmacological activity and this was in agreement with other in vivo 
antimalarial test (48). 
  In 4-day suppressive test, it was only chloroquine treated mice that prevented body weight loss  
(P>0.05) but all the extract treated mice had  shown a statically significant (P<0.05) weight loss 
when compared to negative control. Body weight loss in extract treated mice might be possibly 
due to depressing effect of the crude extract on feed intake or appetite and this result is in 
agreement with that of a previous study on other medicinal plant (41). The result of the present 
study on body weight, however, is not in agreement with that of of Dicasso. (26). The stem bark 
Extract of H.abyssinica showed anti-malarial activity against P. berghei infection in mice as 
evidenced by the percentage of parasite inhibition. As shown from the results of the in vivo 
antiplasmodial studies, the methanol extract of H.abyssinica exhibited highest suppressive 
activity on P. berghei. The plant extracts are less effective when compared to that of the standard 
antimalarial drug, chloroquine phosphate. The effects on parasitemia in this study are similar to 
the ones reported by previous studies such as on Solanum surattense (60),  Piliostigma 
thonningii schum (61) Maerua crassifolia  forssk ( 62),   Croton macrostachyus Hocsht (57) and 
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However, relatively lower  antiplasmodial activities than the present result have been reported on 
Khaya grandifoliola Welw (63), Dodonaea angustifolia  (41). 
  From literature an in vivo anti-plasmodial activity can be classified as moderate, good and very 
good if an extract displayed percent parasitemia suppression equal to or greater than 50% at a 
dose of 500 mg, 250 mg and 100 mg/kg body weight per day, respectively. Based on this 
classification, the parasitemia chemosuppression was greater than  50% at the lowest  doses (100 
mg/kg body weight). It can thus be generally concluded that the hydromethanolic stem bark 
extract of H.abyssinica  exhibited a very good anti-plasmodial activity(57). 
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6. Conclusion 
From this study, it can be concluded that the Acute and subacute toxicity studies showed the non 
toxic effect of the methanol extracts of Stem bark of H. abyssinica. Ethnobotanical knowledge 
was sufficiently reliable for identifying plant extracts with antiplasmodial activity. The results 
obtained from the present work support the traditional use of H. abyssinica against malaria and 
confirmed the Methanol extract of H. abyssinica has parasite suppressive effects against 
Plasmodium berghei infected Swiss albino mice in a dose related manner .Antimalarial activities 
as well as the lack of toxicity of the extracts suggest its ethnopharmacological usefulness as anti 
malarial. Because of the antimalarial activity of the methanol extract, the plant serve as a 
potential source for isolation of lead antimalarial compounds.  
7. Recommendation 
 The identification  & validation of antimalarial active compounds of these traditional 
plants should involve researchers from different disciplines in order to achieve better 
results                                                                                                                                                          
 The active components of the plant extracts need to be purified by bioassay guided 
isolation method and further work must be undertaken  to isolate the active compounds 
responsible for the observed antimalarial activity of the extracts.                                                                                                     
 pharmacological and toxicological studies should be done before drug development.                                                                                                                                                      
  Further investigation as a potential antimalarial in the Atotus Monkey (Aotus trivirgatus) 
against P. falciparum infection will be justifiable. 
 In vivo antimalarial testing should be done on other parts of the plant  like 
flower,leaf,root by using different solvents. 
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9. Appendices 
Annex 1: List of   Equipments:- 
 Electrical balance, disposable glove, oral gavages, measuring cylinder, syringe with 
needle, beakers, mortal and pestle, Buckner funnel, what man no.1 filter paper, surgical 
blade ,slides, pipette, scissor and  microscope, digital thermometer 
Annex 2:Phytochemical screening procedures:- 
1. Detection of alkaloids:Extracts were dissolved individually in dilute Hydrochloric acid and 
filtered.  
a. Mayer’s Test: Filtrates were treated with Mayer’s reagent (Potassium Mercuric 
Iodide).Formation of a yellow coloured precipitate indicates the presence of 
alkaloids.   
b. Dragendroff’s Test:Filtrates were treated with Dragendroff’s reagent (solution of 
Potassium Bismuth Iodide). Formation of red precipitate indicates the presence of 
alkaloids.  
2. Detection of glycosides:Extracts were hydrolysed with dil. HCl, and then subjected to test for 
glycosides.  
a. Modified Borntrager’s Test:Extracts were treated with Ferric Chloride solution 
and immersed in boiling water for about 5 minutes. The mixture was cooled and 
extracted with equal volumes of benzene. The benzene layer was separated and 
treated with ammonia solution. Formation of rose-pink colour in the ammonical 
layer indicates the presence of anthranol glycosides.  
3. Legal’s Test: Extracts were treated with sodium nitropruside in pyridine and sodium 
hydroxide. Formation of pink to blood red colour indicates the presence of cardiac glycosides.  
4. Detection of saponins:-Foam Test: 0.5 gm of extract was shaken with 2 ml of water. If foam 
produced persists for ten minutes it indicates the presence of saponins.  
5. Detection of phytosterols :- Salkowski’s Test:Extracts were treated with chloroform and 
filtered. The filtrates were treated with few drops of Conc. Sulphuric acid, shaken and allowed 
to stand. Appearance of golden yellow colour indicates the presence of triterpenes.  
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6. Detection of phenols :- Ferric Chloride Test:Extracts were treated with 3-4 drops of ferric 
chloride solution. Formation of bluish black colour indicates the presence of phenols.  
7. Detection of tannins :-Gelatin Test: To the extract, 1% gelatin solution containing sodium 
chloride was added. Formation of white precipitate indicates the presence of tannins.  
8. Detection of flavonoids  
a) Alkaline Reagent Test:Extracts were treated with few drops of sodium hydroxide 
solution. Formation of intense yellow colour, which becomes colourless on addition of 
dilute acid, indicates the presence of flavonoids.  
b) Lead acetate Test:Extracts were treated with few drops of lead acetate solution. 
Formation of yellow colour precipitate indicates the presence of flavonoids.  
9. Detection of diterpenes:-   Copper acetate Test: Extracts were dissolved in water and treated 
with 3-4 drops of copper acetate solution. Formation of emerald green colour indicates the 
presence of diterpenes 
10. Detection of antraquinone:-:-1gram of extract is boiled for two minutewith five mlof 0.5N 
KOH  and 0.5mlof 5% H2O2 mixture.after cooling ,the suspention is filtered through the glass 
wool. The filtrate is treated with six drops of acetic acid and the resulting solution is mixedwith 
five ml of tolune.The upper layer is separetedwith a pippat and transferred to a test tube and two 
ml of 0.5N KOH is added.ifared color appears in the aqueous layer ,anthranoids present. 
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